Tyra Biosciences TYRA
NASDAQ TYRA
$20.43 -0.58 (-2.76%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tyra Biosciences (TYRA) Gains from Sales and Divestitures (2021 - 2023)

Updated

Tyra Biosciences (TYRA) posted Gains from Sales and Divestitures of -$4,000 for FY2023, compared with -$3,000 in FY2022.

Analysis

Tyra Biosciences (TYRA) Gains from Sales and Divestitures (2021 - 2023) Analysis & Trends

Since FY2020, Tyra Biosciences has reported Gains from Sales and Divestitures for 4 years.

  • Business Quant data shows TYRA's Gains from Sales and Divestitures at -$3,000 in FY2022, -$3,000 in FY2021 and -$2,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Tyra Biosciences 1.22 Bn 1.22 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 -1,000.00
Jun 30, 2023 -3,000.00
Sep 30, 2022 -1,000.00
Mar 31, 2022 -2,000.00
Sep 30, 2021 -3,000.00
API Access

Tyra Biosciences Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=TYRA&period=max&api_key=YOUR_API_KEY